All In Biotech

Free tool

FAERS Monitor: Implanon

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021529 or its brand name (Implanon, Etonogestrel). Reports on generic versions are filed under their own applications.

Reports

57,570

Serious

13,734

24% of reports

Hospitalization

1,706

Death reported

110

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • no adverse event12,139
  • product quality issue6,915
  • complication associated with device6,622
  • device breakage5,381
  • incorrect product administration duration5,033
  • complication of device insertion4,758
  • device difficult to use4,584
  • complication of device removal4,373
  • unintended pregnancy3,743
  • device deployment issue3,686
  • pregnancy with implant contraceptive3,434
  • vaginal haemorrhage3,434
  • implant site pain3,247
  • device dislocation2,893
  • amenorrhoea2,545

Reports by year received

View as table
YearReports
20041
200634
200788
200856
200956
20103
201155
2012619
20132,766
20143,778
20154,243
20164,828
20174,427
20184,941
20194,845
20203,976
20213,817
20223,505
20231,626
20241,477
20251,819
202610,610

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,996,589 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pregnancy with implant contraceptiveSignal3,434994.0932.3914,336
implant site painSignal3,247965.9905.0857,781
complication associated with deviceSignal6,622305.2295.71,093,626
unintended pregnancySignal3,743203.2195.4483,810
device deployment issueSignal3,686147.7142.3382,419
complication of device removalSignal4,373116.2112.4379,049
complication of device insertionSignal4,758114.5110.9407,638
incorrect product administration durationSignal5,033110.2106.9418,669
amenorrhoeaSignal2,54561.859.3130,303
device breakageSignal5,38155.754.2251,067
vaginal haemorrhageSignal3,43431.330.392,921
device difficult to useSignal4,58427.126.3107,607
no adverse eventSignal12,13926.225.7276,456
device dislocationSignal2,89326.025.064,949
product quality issueSignal6,91519.519.1116,216

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.